1-3 of 3
Peter Vadas, MD
Close
Sort by
Journal Articles

Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis

Cem Akin, MDPhD, Hanneke Oude Elberink, MD PhD, Jason Gotlib, MD MS, Vito Sabato, MD PhD, Karin Hartmann, MD, Sigurd Broesby-Olsen, MD, Mariana Castells, MD PhD, Tsewang Tashi, MD, Mark L Heaney, MD, Tracy I. George, MD, Frank Siebenhaar, MD, Deepti H. Radia, MRCPI, FRCPath, Massimo Triggiani, MD PhD, Paul van Daele, MD, Daniel J. DeAngelo, MD PhD, Iván Alvarez-Twose, MD PhD, Andreas Reiter, MD, Peter Vadas, MD PhD, Patrizia Bonadonna, MD, Paggy Hew, MS, Hui-Min Lin, PhD, Maria Roche, MS, Marcus Maurer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136632
Published: 2020
Journal Articles

A Retrospective Case Series Describing the Efficacy of Omalizumab in Systemic Mastocytosis

Calum Anthony Slapnicar, Conrad Scullion Smeenk, Lisa K. Hicks, MD MSc, Jessica Petrucci, MSc, Peter Vadas, MD, Martina Trinkaus, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5470.
https://doi.org/10.1182/blood-2018-99-118415
Published: 2018
Journal Articles

A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis

Calum Anthony Slapnicar, Conrad Scullion Smeenk, Lisa K. Hicks, MD MSc, Jessica Petrucci, MSc, Peter Vadas, MD, Martina Trinkaus, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5474.
https://doi.org/10.1182/blood-2018-99-120112
Published: 2018